Please ensure Javascript is enabled for purposes of website accessibility

West Bank Town Becomes ‘Big Prison’ as Israel Fences It In

7 hours ago

Trump Says He’s Willing to Let Migrant Farm Laborers Stay in US

8 hours ago

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

1 day ago

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

1 day ago

Trump’s Sweeping Tax-Cut and Spending Bill Wins Congressional Approval

1 day ago

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

1 day ago

US Supreme Court to Decide Legality of Transgender School Sports Bans

1 day ago

Nvidia Set to Become the World’s Most Valuable Company in History

1 day ago

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

1 day ago
Senators Grill Pharmaceutical CEOs About High Drug Prices
gvw_ap_news
By Associated Press
Published 6 years ago on
February 26, 2019

Share

WASHINGTON — Senators grilled CEOs of seven major drug companies on Tuesday over high prescription drug prices that are a drain on Medicare and Medicaid and a burden to millions of Americans. The extraordinary public accounting was a sign that Congress and the White House are moving toward legislation this year to curb costs.

“Without a doubt, drug pricing is a complex issue. But I think we should all be asking: Should it be so complex? We cannot allow anyone to hide behind the current complexities to shield the true cost of a drug.” — Chairman Charles Grassley
As the Finance Committee hearing got underway, Chairman Charles Grassley, R-Iowa, pointedly reminded the executives that it is a crime to provide false testimony to Congress. Some of the companies initially had sought a private meeting to explain their pricing policies, but lawmakers refused and insisted the CEOs appear in public or risk subpoenas.
“Without a doubt, drug pricing is a complex issue,” Grassley said in his prepared opening statement. “But I think we should all be asking: Should it be so complex? We cannot allow anyone to hide behind the current complexities to shield the true cost of a drug.”
Ranking Democrat Ron Wyden of Oregon said in his prepared statement, “You pharma executives are here because the way you do business is unacceptable and unsustainable. Ten companies accounted for half of all profits in the health care sector last fall. Nine of those ten were drug manufacturers.”
In statements submitted to the committee, the CEOs said drug development is a risky and costly undertaking and that prices reflect investment in research and development.

Dems: Time for Medicare to Leverage Purchasing Power

“We recognize that the current state of drug pricing in the U.S. health care system is not sustainable and that patients are facing increasingly high out-of-pocket costs,” AstraZeneca CEO Pascal Soriot said in prepared remarks. “We believe that these issues must be addressed urgently, and we hope to be a constructive partner in finding solutions.”
Tuesday’s hearing marks the first time lawmakers have called the industry’s top executives to account for rising prices. Previous congressional hearings have focused on bad actors who briefly captured national attention, such as former pharma executive Martin Shkreli, who hiked the price of a decades-old infection treatment by more than 5,000 percent.
Besides AstraZeneca, which makes the cholesterol drug Crestor, other companies represented at the hearing were AbbVie, maker of Humira for rheumatoid arthritis and other immune-system conditions; Bristol-Myers Squibb, maker of the blood thinner Eliquis; Johnson & Johnson, maker of Xarelto to prevent blood clots; Merck, maker of Januvia to treat diabetes; Pfizer, maker of Lyrica for nerve pain; and Sanofi, a leading manufacturer of insulin, including the Lantus brand. The drugmakers have collected tens of billions of dollars from government programs in recent years.
Grassley said that he’s not interested in “scapegoating” and that Congress intends to respond to the drug price problem in a “measured and effective” way.
Democrats say it’s time for Medicare to leverage its purchasing power and directly negotiate prices with the industry, a step most Republicans oppose.

Drugmakers Point Finger at Other Industry Players

The pharmaceutical industry is one of the most powerful lobbies in Washington, but Tuesday’s hearing seemed to mark a change in direction. President Donald Trump’s recurring blasts at drugmakers appear to be closer to finding a pathway to legislation.

“For a patient taking a drug that has no competition, the list price is meaningful.” — Chairman Charles Grassley
Drugmakers pointed a finger at other industry players, including middlemen called pharmacy benefit managers, who bargain on behalf of insurers and employers. Rebates paid to middlemen help assure favorable treatment for a medication on an insurer’s list of covered drugs and help keep premiums lower.
But the rebates are not passed on to consumers who use the particular medication, and they can face high copays based on the drug’s list price, not the discounted one. Experts say rebates can also create an incentive to keep raising list prices.
While list prices are going up, some of the CEOs said the net prices their companies receive after discounts and rebates are stable or sometimes declining.
Grassley seemed skeptical of the drugmakers’ argument that high list prices are not really part of the problem.
“For a patient taking a drug that has no competition, the list price is meaningful,” he said.

Offering Solutions of Their Own

The companies offered solutions of their own, some of which echo proposals from the administration or by lawmakers. Among them:
— Allow patients to share in rebates when they buy their medication, a policy proposed by the Trump administration.
— Place a hard limit on cost-sharing and copays for Medicare beneficiaries in the popular Part D prescription program, a change supported by Wyden.
— Make greater use of value based contracts that tie payments for a medication to how well it delivers results.
— Promote the introduction of lower-cost generics and biosimilars, competition that brand manufacturers are often accused of impeding.
Drug costs are squeezing Americans in a number of ways: New medicines for cancer and other diseases often launch with prices exceeding $100,000 per year even as employers are shifting more pharmacy costs onto workers. Less expensive drugs for common ailments like diabetes and asthma often see price hikes of around 10 percent annually. Meanwhile some drugmakers have been buying up once-cheap medicines and hiking prices by 1,000 percent or more.
The U.S. system for pricing drugs is notoriously complex. An expert panel assembled by the National Academy of Medicine in 2017 concluded it is “extremely difficult, if not impossible, for outsiders to ‘follow the money.'”
Critics say this lack of transparency has created a perverse system in which drugmakers, pharmacy benefit managers and other health care providers all benefit from rising prices.
The drug industry’s concerns about government intervention are on the rise. Drugmakers’ top lobbying arm, the Pharmaceutical Research and Manufacturers of America, spent a record $27.9 million last year to sway federal decision makers, according to records tallied by the nonprofit Center for Responsive Politics. That surpassed the group’s previous biggest spending total of $27.1 million during the 2009 congressional battle over President Barack Obama’s health care law, the Affordable Care Act, sometimes called Obamacare.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Trump to Sign Tax-Cut and Spending Bill in July 4 Ceremony

DON'T MISS

Madre Fire Spurs Evacuations Across 3 Counties, Grows to More Than 70,000 Acres

DON'T MISS

Clovis, Sanger, Madera, and Bass Lake Will Light the Sky With Fireworks Shows Tonight

DON'T MISS

Oil Dips Ahead of Expected OPEC+ Output Increase

DON'T MISS

613 Killed at Gaza Aid Distribution Sites, Near Humanitarian Covoys, Says UN

DON'T MISS

Fresno County Authorities Investigating Suspicious Death of Transient Man

DON'T MISS

West Bank Town Becomes ‘Big Prison’ as Israel Fences It In

DON'T MISS

Israeli Military Kills 20 in Gaza as Trump Awaits Hamas Reply to Truce Proposal

DON'T MISS

Valley Crime Stoppers’ Most Wanted Person of the Day: Rachelle Maria Blanco

DON'T MISS

Russia Pounds Kyiv With Largest Drone Attack, Hours After Trump-Putin Call

UP NEXT

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

UP NEXT

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

UP NEXT

Poorest Americans Dealt Biggest Blow Under Senate Republican Tax Package

UP NEXT

Poll: Most Americans Say National Divide, Political Violence Threaten Democracy

UP NEXT

Trump Pulls Back 150 Guard Troops From Federal Duties in California

UP NEXT

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

UP NEXT

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

UP NEXT

US Supreme Court Lets Parents Take Kids Out of Classes With LGBT Storybooks

UP NEXT

Bill Moyers, Broadcaster and LBJ’s White House Press Secretary, Dies at 91

UP NEXT

Tesla Executive, Elon Musk Confidant Leaves EV Maker, Bloomberg News Reports

Oil Dips Ahead of Expected OPEC+ Output Increase

7 hours ago

613 Killed at Gaza Aid Distribution Sites, Near Humanitarian Covoys, Says UN

7 hours ago

Fresno County Authorities Investigating Suspicious Death of Transient Man

7 hours ago

West Bank Town Becomes ‘Big Prison’ as Israel Fences It In

7 hours ago

Israeli Military Kills 20 in Gaza as Trump Awaits Hamas Reply to Truce Proposal

7 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Rachelle Maria Blanco

7 hours ago

Russia Pounds Kyiv With Largest Drone Attack, Hours After Trump-Putin Call

8 hours ago

Boxer Chavez Jr Expected to Be Deported to Mexico to Serve Sentence, Mexican President Says

8 hours ago

Markets’ 90-Day Tariff Pause Rollercoaster Nears an Uncertain End

8 hours ago

Trump Says He’s Willing to Let Migrant Farm Laborers Stay in US

8 hours ago

Trump to Sign Tax-Cut and Spending Bill in July 4 Ceremony

President Donald Trump is scheduled to sign a massive package of tax and spending cuts into law at a ceremony at the White House on Friday, ...

6 hours ago

President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. (Reuters File)
6 hours ago

Trump to Sign Tax-Cut and Spending Bill in July 4 Ceremony

The Madre Fire burning near New Cuyama has scorched 70,801 acres as of Friday, July 4, 2025, afternoon, making it California’s largest wildfire of the year, with only 10% containment and multiple evacuation zones in place. (CalFire)
6 hours ago

Madre Fire Spurs Evacuations Across 3 Counties, Grows to More Than 70,000 Acres

7 hours ago

Clovis, Sanger, Madera, and Bass Lake Will Light the Sky With Fireworks Shows Tonight

A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024. (Reuters File)
7 hours ago

Oil Dips Ahead of Expected OPEC+ Output Increase

Palestinians gather to collect what remains of relief supplies from the distribution center of the U.S.-backed Gaza Humanitarian Foundation, in Rafah, in the southern Gaza Strip, June 5, 2025. (Reuters File)
7 hours ago

613 Killed at Gaza Aid Distribution Sites, Near Humanitarian Covoys, Says UN

Billy Wayne Sinisgalli, a 54-year-old transient known locally as Wayne, was found dead along a rural Fresno road Wednesday in what authorities are investigating as a suspicious death. (Fresno County SO)
7 hours ago

Fresno County Authorities Investigating Suspicious Death of Transient Man

Israel Builds a Fence Around the West Bank
7 hours ago

West Bank Town Becomes ‘Big Prison’ as Israel Fences It In

A view of the site of Thursday's Israeli strike that damaged and destroyed residential buildings, at Shati (Beach) refugee camp, in Gaza City, July 4, 2025. (Reuters/Mahmoud Issa)
7 hours ago

Israeli Military Kills 20 in Gaza as Trump Awaits Hamas Reply to Truce Proposal

Help continue the work that gets you the news that matters most.

Search

Send this to a friend